Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience

BACKGROUND: In this prospective study, the impact of granulocyte colony-stimulating factors (G-2 CSF) administered during induction treatment with bendamustine plus rituximab for indolent non- Hodgkin Llymphoma (NHL) was evaluated by comparing patients who received secondary prophylaxis with filgras...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerchione, Claudio, De Renzo, Amalia, Di Perna, Maria, Della Pepa, Roberta, Pugliese, Novella, Catalano, Lucio, Pane, Fabrizio, Picardi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266775/
https://www.ncbi.nlm.nih.gov/pubmed/27812763
http://dx.doi.org/10.1007/s00520-016-3468-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266775/
https://www.ncbi.nlm.nih.gov/pubmed/27812763
http://dx.doi.org/10.1007/s00520-016-3468-8

Ejemplares similares